02.13.24 -- Relational Risk Analysis For The Bio/Pharma Industry

The growing mRNA vaccine market — projected to reach $127.3 billion by 2027 — is fueling high demand for mRNA, which has resulted in a critical need to address mRNA manufacturing bottlenecks.

Experts discuss key considerations and three primary challenges faced during the development and manufacture of highly potent oral solids.

Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?

This study explores the feasibility of using single-use chromatography membrane technology as an alternative to resin-based chromatography in an ADC process.

Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets and project timelines and identify potential supply-related issues before they negatively impact a study.

How can you optimize your media for chromatography and improve consistency, yield, and purity through the integration of automation technologies such as advanced slurry preparation systems?

Recent technological advances in mass spectrometry-based methods have made it easier to overcome the challenges of glycoprotein analysis.

Discover a collaborative automated sample handler that eliminates manual sample handling, enabling groups to test larger sample sets and collect statistically significant data while freeing up analysts’ time.

A critical issue when transitioning from stainless steel to plastic equipment is the presence of extractables and leachables (E&L). See how BPOG testing on single-use connectors mitigates the risks.

Medtech OEMs, contract manufacturers, and other partners involved in the device life cycle are increasingly realizing additional benefits by making sustainability a group exercise.